Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies
dc.rights.license | open | en_US |
hal.structure.identifier | Groupe de Recherche en Economie Théorique et Appliquée [GREThA] | |
dc.contributor.author | GORRY, Philippe | |
dc.contributor.author | USECHE, D | |
dc.contributor.editor | Berndt, E.R. | |
dc.contributor.editor | Goldman, D.P. | |
dc.contributor.editor | Rowe, J. | |
dc.date.accessioned | 2020-06-23T07:35:04Z | |
dc.date.available | 2020-06-23T07:35:04Z | |
dc.date.issued | 2019 | |
dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/8085 | |
dc.language.iso | EN | en_US |
dc.publisher | University of Chicago Press Books | en_US |
dc.source.title | Economic Dimensions of Personalized and Precision Medicine | en_US |
dc.title.en | Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies | |
dc.title.alternative | Economic Dimensions of Personalized and Precision Medicine | en_US |
dc.type | Chapitre d'ouvrage | en_US |
dc.identifier.doi | 10.7208/chicago/9780226611235.003.0011 | |
dc.subject.hal | Sciences du Vivant [q-bio]/Santé publique et épidémiologie | en_US |
bordeaux.hal.laboratories | Bordeaux Population Health Research Center (BPH) - UMR 1219 | en_US |
bordeaux.institution | Université de Bordeaux | en_US |
bordeaux.inpress | non | en_US |
hal.identifier | hal-02152424 | |
hal.version | 1 | |
hal.date.transferred | 2021-04-28T08:39:23Z | |
hal.export | true | |
bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.btitle=Economic%20Dimensions%20of%20Personalized%20and%20Precision%20Medicine&rft.date=2019&rft.au=GORRY,%20Philippe&USECHE,%20D&rft.genre=unknown |